Regenerative medicine company Acepodia announced on the 11th that its co-founder and chairman, Patrick Y. Yang, will officially retire at the end of this year. The board has unanimously approved the appointment of the current CEO, Sonny Hsiao, as chairman, effective 2025, to lead the company into its next phase of development. Acepodia also announced plans to hold an extraordinary general meeting to elect an additional board member, nominating 2022 Nobel Chemistry laureate Dr. Carolyn Bertozzi as a candidate.
Read more
